Trial Profile
Placebo controlled trial of bosentan vs placebo in NYHA class I/II sclerodoma patients with exercise induced pulmonary hypertension.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Exercise-induced hypertension
- Focus Pharmacodynamics
- 19 Jul 2011 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
- 14 Jul 2010 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 04 Dec 2006 New trial record.